Authors of Largest Microdosing Study Suggest Benefits Limited To Dosing Day
New RAND Report Shows Therapeutic Use Driving U.S. Views Towards Psychedelics
Oregon’s Psilocybin Program: Industry Insiders Weigh In On Closures and the Future
Varying Approaches to Psychedelic Policy Reform in Washington State
Legislation, Industry, and the Future of Psilocybin for PTSD 
New Theories and Findings From The Frontier of Ibogaine Research 
NJ Psilocybin Legislation Exposes Conflicts Between Advocates for Different Therapeutic  Models
Partners Announced for Texas Ibogaine Research Consortium Funding
From Nepal to Podcasts: The Viral Rise of Hallucinogenic “Mad Honey”
Latinas in Psychedelics: Building Community, Honoring Heritage, and Shaping the Future
The High Stakes of Low Tolerance: Jeremy O. Harris’ Arrest, Detention, and Release in Japan
New Mexico to Accelerate Its Launch of Therapeutic Psilocybin Access
Freedom To Heal Act Gathers Support
Exploring the Boundary Between Genius and Delusion in Terence McKenna’s Life
The Attorney Leading the Fight to Bring Psychedelics to the Dying